A detailed history of Kathmere Capital Management, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 1,992 shares of MCK stock, worth $1.15 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,992
Previous 2,163 7.91%
Holding current value
$1.15 Million
Previous $1.26 Million 22.09%
% of portfolio
0.1%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$479.06 - $630.38 $81,919 - $107,794
-171 Reduced 7.91%
1,992 $984,000
Q2 2024

Jul 17, 2024

SELL
$518.81 - $607.81 $72,633 - $85,093
-140 Reduced 6.08%
2,163 $1.26 Million
Q2 2024

Jul 01, 2024

SELL
$518.81 - $607.81 $85,603 - $100,288
-165 Reduced 6.69%
2,303 $1.35 Million
Q1 2024

Apr 16, 2024

BUY
$473.42 - $539.26 $78,114 - $88,977
165 Added 7.16%
2,468 $1.32 Million
Q4 2023

Apr 16, 2024

SELL
$437.42 - $470.64 $44,179 - $47,534
-101 Reduced 4.2%
2,303 $1.07 Million
Q3 2023

Oct 11, 2023

BUY
$402.4 - $446.42 $97,380 - $108,033
242 Added 11.19%
2,404 $1.05 Million
Q2 2023

Jul 11, 2023

BUY
$354.01 - $427.31 $105,140 - $126,911
297 Added 15.92%
2,162 $923,000
Q1 2023

Apr 20, 2023

SELL
$335.35 - $386.06 $75,118 - $86,477
-224 Reduced 10.72%
1,865 $664,000
Q4 2022

Jan 24, 2023

SELL
$346.68 - $397.58 $19,414 - $22,264
-56 Reduced 2.61%
2,089 $0
Q4 2022

Jan 24, 2023

BUY
$346.68 - $397.58 $173,340 - $198,790
500 Added 30.4%
2,145 $0
Q3 2022

Oct 11, 2022

BUY
$321.25 - $373.84 $115,328 - $134,208
359 Added 27.92%
1,645 $559,000
Q2 2022

Aug 09, 2022

BUY
$300.57 - $336.42 $81,755 - $91,506
272 Added 26.82%
1,286 $420,000
Q1 2022

Apr 28, 2022

BUY
$244.61 - $310.48 $248,034 - $314,826
1,014 New
1,014 $310,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.